| Dr Gregory Theodore Classen, DO | |
|
885 Aurora Rd, Sagamore Hills, OH 44067-1600 | |
| (330) 468-4554 | |
| Not Available |
| Full Name | Dr Gregory Theodore Classen |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 885 Aurora Rd, Sagamore Hills, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841220233 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 34002808 (Ohio) | Primary |
| Entity Name | Wound Care Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831495373 PECOS PAC ID: 2567646359 Enrollment ID: O20110401000409 |
News Archive
Cross-group friendships have a positive effect on intergroup attitudes among children and adolescents, according to a new issue of the International Journal of Behavioral Development, published this month.
Consumer-directed health plans offer low premiums but high deductibles on the premise that patients who are faced with deductibles of $1,000 or more for individual coverage (or twice that for family coverage) will shop around for the best price for the health care.
From birthday cakes to Thanksgiving pie to cold summer treats, every holiday, season or special occasion harkens mouth-watering memories of a favorite sugary treat.
A clinical trial will examine an investigational drug's early bacteria-killing activity in patients newly diagnosed with drug-sensitive pulmonary tuberculosis.
Therakos, Inc., a pioneer in the innovative treatment of extracorporeal photopheresis (ECP) for immune modulation therapy, today announced that the first patient has been enrolled in its Phase IIb clinical study evaluating the use of the company's photopheresis technology in the treatment of patients with moderate-to-severe chronic Graft-versus-Host Disease (GvHD).
› Verified 7 days ago
| Entity Name | Providercare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740736818 PECOS PAC ID: 1254610660 Enrollment ID: O20161107002393 |
News Archive
Cross-group friendships have a positive effect on intergroup attitudes among children and adolescents, according to a new issue of the International Journal of Behavioral Development, published this month.
Consumer-directed health plans offer low premiums but high deductibles on the premise that patients who are faced with deductibles of $1,000 or more for individual coverage (or twice that for family coverage) will shop around for the best price for the health care.
From birthday cakes to Thanksgiving pie to cold summer treats, every holiday, season or special occasion harkens mouth-watering memories of a favorite sugary treat.
A clinical trial will examine an investigational drug's early bacteria-killing activity in patients newly diagnosed with drug-sensitive pulmonary tuberculosis.
Therakos, Inc., a pioneer in the innovative treatment of extracorporeal photopheresis (ECP) for immune modulation therapy, today announced that the first patient has been enrolled in its Phase IIb clinical study evaluating the use of the company's photopheresis technology in the treatment of patients with moderate-to-severe chronic Graft-versus-Host Disease (GvHD).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory Theodore Classen, DO 885 Aurora Rd, Sagamore Hills, OH 44067-1600 Ph: (330) 468-4554 | Dr Gregory Theodore Classen, DO 885 Aurora Rd, Sagamore Hills, OH 44067-1600 Ph: (330) 468-4554 |
News Archive
Cross-group friendships have a positive effect on intergroup attitudes among children and adolescents, according to a new issue of the International Journal of Behavioral Development, published this month.
Consumer-directed health plans offer low premiums but high deductibles on the premise that patients who are faced with deductibles of $1,000 or more for individual coverage (or twice that for family coverage) will shop around for the best price for the health care.
From birthday cakes to Thanksgiving pie to cold summer treats, every holiday, season or special occasion harkens mouth-watering memories of a favorite sugary treat.
A clinical trial will examine an investigational drug's early bacteria-killing activity in patients newly diagnosed with drug-sensitive pulmonary tuberculosis.
Therakos, Inc., a pioneer in the innovative treatment of extracorporeal photopheresis (ECP) for immune modulation therapy, today announced that the first patient has been enrolled in its Phase IIb clinical study evaluating the use of the company's photopheresis technology in the treatment of patients with moderate-to-severe chronic Graft-versus-Host Disease (GvHD).
› Verified 7 days ago